Showing results (251-260 of 5,645) with videos related to
Sort By:
Pageof 565
Drug Design, Development and Therapy|May 1, 2013
Find novel dual-agonist drugs for treating type 2 diabetes by means of cheminformaticsLei Liu, Ying Ma, Run-Ling Wang, et al.Drug Design, Development and Therapy|May 1, 2013
Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantationIbrahim Gueler, Susanne Mueller, Matthias Helmschrott, et al.Drug Design, Development and Therapy|April 27, 2013
Profile of certolizumab and its potential in the treatment of psoriatic arthritisMaria Sole Chimenti, Rosita Saraceno, Andrea Chiricozzi, et al.Drug Design, Development and Therapy|August 1, 2013
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fractureMaurizio Rossini, Stefano Lello, Ignazio Sblendorio, et al.Drug Design, Development and Therapy|June 29, 2013
Preparation and evaluation of a multimodal minoxidil microemulsion versus minoxidil alone in the treatment of androgenic alopecia of mixed etiology: a pilot studyFarouk M Sakr, Ali Mi Gado, Haseebur R Mohammed, et al.Drug Design, Development and Therapy|May 11, 2012
A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteersGeorg Golor, Ke Hu, Matthieu Ruffin, et al.Drug Design, Development and Therapy|November 19, 2009
Comparative in vivo bioequivalence and in vitro dissolution of two valproic acid sustained-release formulationsAkira Fujii, Norio Yasui-Furukori, Taku Nakagami, et al.Drug Design, Development and Therapy|November 19, 2009
Transdermal hormone therapy in postmenopausal women: a review of metabolic effects and drug delivery technologiesNathan W Kopper, Jennifer Gudeman, Daniel J ThompsonDrug Design, Development and Therapy|November 19, 2009
Development and targeted use of nilotinib in chronic myeloid leukemiaCarmen Fava, Hagop Kantarjian, Jorge Cortes, et al.Drug Design, Development and Therapy|November 19, 2009
Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastasesThomas J PolascikPageof 565